Uncategorized

Forbearance requests slow sharply in legacy RMBS

| June 26, 2020

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

Based on an early read of June remittance data, it appears the number of legacy private MBS borrowers either newly entering forbearance or falling behind on a first payment fell drastically in May. The pace of delinquency increases and forbearance uptake fell by roughly 50% month-over-month, driven by outsized declines in larger loans and loans in areas that have seen the most impact from COVID-19.

While still very much an incomplete picture, delinquency rates and forbearance uptake by legacy borrowers slowed precipitously this month across all flavors of legacy RMBS. Prime and subprime loans saw the biggest slowdowns with the drop in prime loans led by larger balances. Somewhat surprisingly, forbearance requests fell sharply as well in states most affected by the virus such as New York and New Jersey, where forbearance uptake fell roughly in line with Texas, Florida and Nevada.

Based on early remittance data across roughly 20% of the legacy universe, the amount of loans entering forbearance in May either through delinquency or capitalization of a missed payment fell by roughly 50% month-over-month. May remittance data that reflected the April payment cycle showed that the amount of borrowers entering forbearance plans increased between 12% and 14% across legacy RMBS cohorts. That number fell to between 5.5% and 8% in this month’s remittance. Forbearance uptake fell equally across prime and subprime cohorts as the amount of loans entering forbearance fell by 7.5%, representing a 57% decline across both credits. Conversely Option ARM collateral saw a modestly smaller slowdown in roll rates as they fell from roughly 14% to 8% over the two-month period. (Exhibit1)

Exhibit 1: Forbearance uptake falls across legacy credits in June

Source: Amherst Insight Labs, Amherst Pierpont Securities

Forbearance trends by loan balance

Much has been made of the lower levels of forbearance in smaller balance loans as there has been significant discussion of the possibility that fiscal stimuli such as the PPP program, increased unemployment benefits and stimulus checks have helped to keep levels of forbearance low for borrowers with more affordable payments (here). Government support would help more in servicing lower nominal amounts of debt than larger ones. One alternative theory on the disproportionately large forbearance uptake in higher loan balances is that higher cost states and cities have borne the brunt of the virus’ impact as areas like New York and New Jersey have been disproportionately impacted relative to other lower cost areas of the country.

Even with these programs still in place, the disparity in forbearance uptake between lower and higher balance loans converged significantly this month as uptake rates on higher loan balance loans fell dramatically in June. Forbearance uptake fell by more than 60% month-over-month on loans with balances between $600,000 and $1,000,000. However, forbearance uptake rates on super-jumbo balance loans remained elevated relative to almost all other cohorts (Exhibit 2).

Exhibit 2: Forbearance uptake begins to converge across loan size

Source: Amherst Insight Labs, Amherst Pierpont Securities

Additionally, if it is the case that existing fiscal stimulus is driving lower rates of forbearance across lower loan balance loans, it seems plausible that as these programs expire, there may be a significant spike in forbearance uptake by lower loan balance borrowers as these benefits are no longer available to aid borrowers. In that instance, forbearance uptake on lower loan balance loans may in fact begin to increase in-line with peak forbearance rates seen last month in higher loan balance loans.

Forbearance trends by geography

Surprisingly, forbearance requests converged to roughly 6% nominally in this month’s remittance across all major states. New York, which saw 21% of previously current borrowers either transition to delinquency or receive a capitalization modification in last month’s remittance, saw that number fall to just 6.9% this month, representing a roughly 70% decline month-over-month. The swift and steep decline in forbearance requests in New York comes as somewhat of a surprise given the broad shutdown of large portions of the state’s economy through May. New Jersey saw a similar decrease in this month’s remittance while other major states saw a roughly 50% decline. (Exhibit 3)

Exhibit 3: Forbearance requests normalize across states this month

Source: Amherst Insight Labs, Amherst Pierpont Securities

With the obvious caveat that these are still increases in the absolute levels of delinquencies and the fact that this 20% may not be a representative sample of the broader legacy universe, the material slowdown in forbearance uptake, especially in states hardest hit by COVID-19, appears to be a positive data point for investors in the legacy sector. Fundamental performance will ultimately be driven by what percentage of these borrowers cure and re-perform after exiting their forbearance plans. However, given the large stores of built up borrower equity in the legacy sector coupled with relatively strong home price performance over recent months, it seems likely that the impact to the sector may be quite muted especially relative to certain other areas of mortgage credit.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles